BioMarin Pharmaceutical Inc. buy Citigroup Inc.
Start price
19.05.26
/
50%
€42.91
Target price
19.05.27
€64.43
Performance (%)
20.72%
Price
10.07.26
€51.80
Summary
This prediction is currently active. The prediction currently has a performance of 20.72%. This prediction currently runs until 19.05.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | 0.739% | 0.739% |
| iShares Core DAX® | -3.173% | 1.229% |
| iShares Nasdaq 100 | -1.006% | 0.381% |
| iShares Nikkei 225® | -3.600% | 1.005% |
| iShares S&P 500 | 0.214% | 2.924% |
Comments by Citigroup_Inc_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) is now covered by Citigroup Inc.. They set a "buy" rating and a $75.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat